Serotonin receptor and transporter ligands - current status

Area of Science:

• Neuroscience
• Pharmacology
• Medicinal Chemistry

Background:

• The serotonin (5-HT) system comprises 14 receptor subtypes, crucial for various physiological functions.
• Ligands targeting 5-HT receptors are vital for treating severe human diseases.
• Existing ligands often feature specific pharmacophores like 4-arylpiperazine and benzimidazole.

Purpose of the Study:

• To review recent advancements in serotonin receptor and transporter specific ligands.
• To analyze the pharmacological properties of these ligands based on their chemical structures.
• To highlight the development of novel ligands for therapeutic and diagnostic applications.

Main Methods:

• Literature review of recent developments in 5-HT ligand research.
• Analysis of chemical structures and pharmacophore elements of identified ligands.
• Examination of binding affinity, selectivity, and pharmacological properties.

Main Results:

• Development of ligands with diverse chemical structures (e.g., 4-arylpiperazine, tetralin) targeting specific 5-HT receptor subtypes.
• Identification of secondary amine derivatives like paroxetine exhibiting high affinity and selectivity.
• Introduction of radioisotope-labeled ligands for in vivo imaging of 5-HT receptors and transporters.

Conclusions:

• Chemical structure is key to achieving high affinity and selectivity for 5-HT receptor and transporter ligands.
• Novel ligands offer improved therapeutic and diagnostic potential for neurological and psychiatric disorders.
• Radio-labeled ligands enable precise brain imaging of target engagement.